Evaluation of AI-Generated Synthetic Data for Clinical Research in Secondary Cardiovascular Prevention among Dyslipidemia Patients
Bonomi, A.; Werba, J. P.; Saccani, S.; Lu, L. L.; Coser, A.; Franchi, M.; Valsecchi, C.; Teruzzi, E.; Terragni, A.; Centenaro, C.; Scatigna, M.; Pompilio, G.
Show abstract
Background: Access to high-quality clinical data is essential for advancing medical research and developing effective medical statistical and Artificial Intelligence models. However, privacy regulations and logistical barriers often hinder timely access to real-world data. Synthetic data offer a promising solution, preserving the statistical characteristics of original datasets while protecting patient privacy. Objectives: This study investigates the use of synthetic data for secondary cardiovascular prevention in patients with dyslipidemia, using two real-world datasets from Centro Cardiologico Monzino. Methods: Given the high dimensionality and limited sample size of the datasets, we employed a custom generative framework based on Large Language Models (LLMs). Pre-trained LLMs were fine-tuned on original clinical records to synthesize tabular data replicating source-data distributions. Fine-tuning was performed within the Centro Cardiologico Monzino's secure infrastructure to ensure data sovereignty. We evaluate clinical utility and privacy using fidelity and privacy metrics, identifying the optimal generative model and benchmarking against traditional anonymization methods. Results: Synthetic data achieved a superior trade-off than classically anonymized datasets. Real and synthetic datasets showed strong agreement, with significant distributional differences limited to few variables. Models trained on synthetic data replicated key associations from the original dataset, including therapy modification and creatine phosphokinase as predictors of SAMS, and pharmacological intensity as the main driver of LDL-C reduction. Conclusions: Results support the feasibility of using synthetic data as a proxy for real-world datasets in exploratory analyses and model development. Despite slight attenuation of some effect sizes, preserved clinical relationships reinforce the validity of synthetic data in medical research.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Privacy-Preserving Federated Neural Network Learning for Disease-Associated Cell Classification 95%
- Generating hard-to-obtain information from easy-to-obtain information: applications in drug discovery and clinical inference 93%
- Federated Learning for multi-omics: a performance evaluation in Parkinson's disease 93%
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- Subpopulation-specific Machine Learning Prognosis for Underrepresented Patients with Double Prioritized Bias Correction 94%
- Bayesian combination of mechanistic modeling and machine learning (BaM3): improving personalized tumor growth predictions 92%
- Forecasting hospital-level COVID-19 admissions using real-time mobility data 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.